{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:54:59Z","timestamp":1773694499583,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s10557-005-6896-0","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T08:07:16Z","timestamp":1117181236000},"page":"41-48","source":"Crossref","is-referenced-by-count":11,"title":["Antiplatelet and Antithrombotic Activity of Cilostazol is Potentiated by Dipyridamole in Rabbits and Dissociated from Bleeding Time Prolongation"],"prefix":"10.1007","volume":"19","author":[{"given":"Haiquan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Cone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masuhiro","family":"Yoshitake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongge","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1022186402442","volume":"16","author":"Y Shakur","year":"2002","unstructured":"Shakur Y, Fong M, Hensley J, et al. Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart. Cardiovascular Drugs and Therapy 2002;16:417\u2013427.","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"CR2","unstructured":"Ikeda Y, Sudo T, Kimura Y. Cilostazol. In: Michelson AD, ed. Platelets. Academic Press, 2002:817\u2013823."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1527-3466.2001.tb00076.x","volume":"19","author":"Y Liu","year":"2001","unstructured":"Liu Y, Shakur Y, Yoshitake M, et al. Cilostazol (Pletal): A dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovasc Drug Rev 2001;19:369\u2013386.","journal-title":"Cardiovasc Drug Rev"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2174\/1381612033453910","volume":"9","author":"J Kambayashi","year":"2003","unstructured":"Kambayashi J, Liu Y, Sun B, et al. Cilostazol as a unique antithrombotic agent. Curr Pharm Des 2003;9:2289\u20132308.","journal-title":"Curr Pharm Des"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00005344-200111000-00014","volume":"38","author":"S Wang","year":"2001","unstructured":"Wang S, Cone J, Fong M, et al. Interplay between inhibition of adenosine uptake and phosphodiesterase type 3 on cardiac function by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol 2001;38:775\u2013783.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00005344-200009000-00011","volume":"36","author":"Y Liu","year":"2000","unstructured":"Liu Y, Fong M, Cone J, et al. Inhibition of adenosine uptake and augmentation of ischemia-induced increase of interstitial adenosine by cilostazol, an agent to treat intermittent claudication. J Cardiovasc Pharmacol 2000;36:351\u2013360.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005344-200210000-00011","volume":"40","author":"B Sun","year":"2002","unstructured":"Sun B, Le SN, Lin S, et al. New mechanism of action for cilostazol: Interplay between adenosine and cilostazol in inhibiting platelet activation. J Cardiovasc Pharmacol 2002;40:577\u2013585.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00005344-199910000-00004","volume":"34","author":"J Cone","year":"1999","unstructured":"Cone J, Wang S, Tandon N, et al. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol 1999;34:497\u2013504.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005344-200408000-00017","volume":"44","author":"Y Liu","year":"2004","unstructured":"Liu Y, Cone J, Le SN, et al. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation. J Cardiovasc Pharmacol 2004;44:266\u2013273.","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"IV3","DOI":"10.1161\/01.CIR.83.6.2122","volume":"83","author":"J Folts","year":"1991","unstructured":"Folts J. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. Circulation 1991;83:IV3\u2013IV14.","journal-title":"Circulation"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1096\/fasebj.4.13.2210155","volume":"4","author":"LR Bush","year":"1990","unstructured":"Bush LR, Shebuski RJ. in vivo models of arterial thrombosis and thrombolysis. FASEB J 1990;4:3087\u20133098.","journal-title":"FASEB J"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jocn.2003.10.022","volume":"11","author":"JS Kim","year":"2004","unstructured":"Kim JS, Lee KS, Kim YI, et al. A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: Analysis with quantitative bleeding time and platelet aggregation test. J Clin Neurosci 2004;11:600\u2013602.","journal-title":"J Clin Neurosci"},{"issue":"Suppl 2","key":"CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00003088-199937002-00010","volume":"37","author":"S Mallikaarjun","year":"1999","unstructured":"Mallikaarjun S, Forbes WP, Bramer SL. Interaction potential and tolerability of the coadministration of cilostazol and aspirin. Clin Pharmacokinet 1999;37(Suppl 2):87\u201393.","journal-title":"Clin Pharmacokinet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0741-5214(03)01029-2","volume":"38","author":"DB Wilhite","year":"2003","unstructured":"Wilhite DB, Comerota AJ, Schmieder FA, et al. Managing PAD with multiple platelet inhibitors: The effect of combination therapy on bleeding time. J Vasc Surg 2003;38:710\u2013713.","journal-title":"J Vasc Surg"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","volume":"143","author":"HC Diener","year":"1996","unstructured":"Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1\u201313.","journal-title":"J Neurol Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0378-4347(99)00104-8","volume":"728","author":"CJ Fu","year":"1999","unstructured":"Fu CJ, Tata PN, Okada K, et al. Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1999;728:251\u2013262.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/01.ANE.0000099366.73625.DD","volume":"98","author":"E Marret","year":"2004","unstructured":"Marret E, Bonnin P, Mazoyer E, et al. The effects of a polymerized bovine-derived hemoglobin solution in a rabbit model of arterial thrombosis and bleeding. Anesth Analg 2004;98:604\u2013610.","journal-title":"Anesth Analg"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/sj.bjp.0704204","volume":"133","author":"T Sudo","year":"2001","unstructured":"Sudo T, Ito H, Ozeki Y, et al. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. Br J Pharmacol 2001;133:1396\u20131404.","journal-title":"Br J Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-200403000-00007","volume":"15","author":"H Kariyazono","year":"2004","unstructured":"Kariyazono H, Nakamura K, Arima J, et al. Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood. Blood Coagul Fibrinolysis 2004;15:157\u2013167.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0049-3848(90)90079-R","volume":"57","author":"T Igawa","year":"1990","unstructured":"Igawa T, Tani T, Chijiwa T, et al. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res 1990;57:617\u2013623.","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199937002-00001","volume":"37","author":"SL Bramer","year":"1999","unstructured":"Bramer SL, Forbes WP, Mallikaarjun S. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease. Clin Pharmacokinet 1999;37 (Suppl 2):1\u201311.","journal-title":"Clin Pharmacokinet"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","volume":"159","author":"HG Beebe","year":"1999","unstructured":"Beebe HG, Dawson DL, Cutler BS, et al. A new pharmacological treatment for intermittent claudication: Results of a randomized, multicenter trial. Arch Intern Med 1999;159:2041\u20132050.","journal-title":"Arch Intern Med"},{"key":"CR23","first-page":"269","volume":"29","author":"Y Tamai","year":"1999","unstructured":"Tamai Y, Takami H, Nakahata R, et al. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus. Haemostasis 1999;29:269\u2013276.","journal-title":"Haemostasis"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.51.3_Suppl_3.S15","volume":"51","author":"JG Tijssen","year":"1998","unstructured":"Tijssen JG. Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: A review of clinical trial results. Neurology 1998;51:S15\u2013S16.","journal-title":"Neurology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0735-1097(01)01270-0","volume":"37","author":"U Schmidt","year":"2001","unstructured":"Schmidt U, Han RO, DiSalvo TG, et al. Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. J Am Coll Cardiol 2001;37:1981\u20131988.","journal-title":"J Am Coll Cardiol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1055\/s-0037-1615232","volume":"80","author":"JM Herbert","year":"1998","unstructured":"Herbert JM, Dol F, Bernat A, et al. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 1998;80:512\u2013518.","journal-title":"Thromb Haemost"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0049-3848(00)00398-4","volume":"101","author":"M Elg","year":"2001","unstructured":"Elg M, Carlsson S, Gustafsson D. Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits. Thromb Res 2001;101:159\u2013 170.","journal-title":"Thromb Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1055\/s-0038-1657701","volume":"78","author":"J Himber","year":"1997","unstructured":"Himber J, Kirchhofer D, Riederer M, et al. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function. Thromb Haemost 1997;78:1142\u20131149.","journal-title":"Thromb Haemost"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09537100410001682779","volume":"15","author":"S Nomura","year":"2004","unstructured":"Nomura S, Inami N, Iwasaka T, et al. Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: Therapeutic effects by cilostazol and potentiation by dipyridamole. Platelets 2004;15:167\u2013172.","journal-title":"Platelets"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-005-6896-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-005-6896-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-005-6896-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:27:56Z","timestamp":1559222876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-005-6896-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["6896"],"URL":"https:\/\/doi.org\/10.1007\/s10557-005-6896-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}